Compostela, Spain; CIBER Fisiopatologı ́a de la Obesidad y Nutricion (CIBERobn),
Santiago de Compostela, Spain
BERNHARDLU ̈SCHER Institute of Biochemistry and Molecular Biology, Medical School,
RWTH Aachen University, Aachen, Germany
FLORENCEMAILLEUX Pole of Cardiovascular Research, Institut de Recherche Expe ́rimentale
et Clinique, Universite ́ catholique de Louvain, Brussels, Belgium
SARAHJ. MANCINI Institute of Cardiovascular and Medical Sciences, College of Medical,
Veterinary and Life Sciences, University of Glasgow, Glasgow, UK
PHILIPPEMARCHETTI Univ. Lille, Inserm, CHU Lille, UMR-S 1172—JPArc—Centre de
Recherche Jean-Pierre AUBERT, Lille, France
TRACIMARIN Cardiopulmonary Sciences, Schools of Allied Health Professions and Medicine,
Loma Linda University, Loma Linda, CA, USA
CLAUDIAMARINANGELI Univ. Lille, Inserm, CHU Lille, UMR-S 1172—JPArc—Centre de
Recherche Jean-Pierre AUBERT, Lille, France
AIDAMARTINEZ-SANCHEZ Section of Cell Biology and Functional Genomics, Division of
Diabetes, Endocrinology and Metabolism, Imperial College London, London, UK
TAKAFUMIMIYAMOTO Department of Internal Medicine (Endocrinology and Metabolism),
Faculty of Medicine, University of Tsukuba, Ibaraki, Japan
JESSEI. MOBBS Department of Biochemistry and Molecular Biology, Bio21 Molecular
Science and Biotechnology Institute, The University of Melbourne, Parkville, VIC,
Australia; Department of Biochemistry and Molecular Biology, School of Biomedical
Sciences, Monash University, Clayton, VIC, Australia
JOHANNAMONDE ́SIR U1016, Institut Cochin, Inserm, Paris, France; UMR8104, CNRS,
Paris, France; Universite ́ Paris Descartes, Paris, France; Equipe Labellise ́e Ligue Nationale
Contre le Cancer (LNCC), Paris, France
DIANAMOREIRA Parasite Disease Group, IBMC-Instituto de Biologia Molecular e Celular,
Universidade do Porto, Porto, Portugal; Instituto de Investigac ̧a ̃o e Inovac ̧a ̃o em Sau ́de,
Universidade do Porto, Porto, Portugal; Departamento de Cieˆncias Biologicas, Faculdade
de Farma ́cia, Universidade do Porto, Porto, Portugal; Life and Health Sciences Research
Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal; ICVS/3Bs-PT
Government Associate Laboratory, Guimara ̃es, Braga, Portugal
RE ́MIMOUNIER Institut NeuroMyoge`ne, CNRS UMR 5310, INSERM U1217, Universite ́
Claude Bernard Lyon 1, Villeurbanne, France
MIRANDANABBEN Department of Molecular Genetics, CARIM School for Cardiovascular
Diseases, Maastricht University, Maastricht, The Netherlands
DIETBERTNEUMANN Department of Pathology, CARIM School for Cardiovascular Diseases,
Maastricht University, Maastricht, The Netherlands
MARIE-SOPHIENGUYEN-TU Section of Cell Biology and Functional Genomics, Division of
Diabetes, Endocrinology and Metabolism, Imperial College London, London, UK
JONATHANS. OAKHILL Metabolic Signalling Laboratory, St. Vincent’s Institute of Medical
Research, Fitzroy, VIC, Australia; Mary MacKillop Institute for Health Research,
Australian Catholic University, Melbourne, VIC, Australia
SE ́VERINEOLIVIER U1016, Institut Cochin, Inserm, Paris, France; UMR8104, CNRS,
Paris, France; Universite ́ Paris Descartes, Paris, France
KAZUHIROOMI Division of Nephrology and Hypertension, Department of Medicine, USC/
UKRO Kidney Research Center, Keck School of Medicine of USC, Los Angeles, CA, USA
xiv Contributors